chronic myeloproliferative disorder: A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
445 |
4. Check minimum number of eventsNone |
445 |
5. Include endpointsNone |
445 |
6. Filter based on genotype QC (FinnGen only) |
445 |
Control definitions (FinnGen only)
- Control exclude
- MYELOPROF
Extra metadata
- First used in FinnGen datafreeze
- DF2, additional
Chronic myeloproliferative disease
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2801 | 1352 | 1414 |
| Only index persons | 2074 | 1031 | 1043 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 70.78 | 71.37 | 70.24 |
| Only index persons | 69.56 | 69.80 | 69.34 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 445 | 202 | 243 |
| Unadjusted period prevalence (%) | 0.09 | 0.07 | 0.11 |
| Median age at first event (years) | 67.54 | 66.15 | 68.69 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 396
- Matched controls
- 3961
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
323.0
396
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
186.9
304.8
298
63
L01XX05
ATC
hydroxycarbamide; oral
1318.4
227.0
200
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
174.2
154
*
D45
ICD-10 Finland
Polycythaemia vera
+∞
155.8
139
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
134.2
121
*
XW000
NOMESCO Finland
Bone marrow biopsy
30.5
110.6
152
79
174
Kela drug reimbursment
Ruxolitinib
+∞
99.2
91
*
D75.2
ICD-10 Finland
Essential thrombocytosis
315.3
98.5
96
*
374
Kela drug reimbursment
Ruxolitinib
+∞
84.4
78
*
L01XE18
ATC
[U] ruxolitinib; oral
+∞
72.1
67
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
68.8
64
*
L01EJ01
ATC
ruxolitinib; oral
+∞
65.4
61
*
M04AA01
ATC
allopurinol; systemic
7.6
61.5
173
367
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
55.5
52
*
WW500
NOMESCO Finland
Blood transfusion
16.1
54.7
92
73
L03AB05
ATC
interferon alfa-2b; parenteral
207.6
53.4
54
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
63.9
52.3
60
11
L01XX35
ATC
anagrelide; oral
+∞
50.1
47
*
B03XA02
ATC
darbepoetin alfa; parenteral
23.8
49.2
71
36
TPH00
NOMESCO Finland
Phlebotomy
129.6
43.8
46
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
+∞
42.5
40
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.1
41.6
131
297
SPAT1074
SPAT
Venesection
+∞
31.7
30
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
51.2
27.9
33
7
D64.9
ICD-10 Finland
Anaemia, unspecified
4.2
22.6
95
274
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.8
22.3
81
202
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
53.1
21.4
25
5
B99
ICPC
Blood/lymph/spleen disease other
44.3
20.7
25
6
B03XA01
ATC
erythropoietin; parenteral
25.0
20.2
28
12
L03AB04
ATC
interferon alfa-2a; parenteral
210.0
19.7
20
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
210.0
19.7
20
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
198.9
18.7
19
*
212
Kela drug reimbursment
Gout
10.8
17.3
33
33
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
17.0
85
281
306
Kela drug reimbursment
Erythropoietin and darbepoetin
36.8
16.8
21
6
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
29.0
16.7
22
8
L03AA04
ATC
NA
+∞
14.7
14
*
R50.9
ICD-10 Finland
Fever, unspecified
3.1
14.6
90
344
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
22.1
13.5
19
9
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
29.5
13.1
17
6
R04.0
ICD-10 Finland
Epistaxis
3.6
12.7
59
182
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
134.0
12.5
13
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
134.0
12.5
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
11.8
149
839
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
13.1
11.8
20
16
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
11.5
11
*
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
+∞
11.5
11
*
B01AC14
ATC
[U] anagrelide; oral
+∞
11.5
11
*
127
Kela drug reimbursment
Transplant complication
8.7
11.5
24
29
C03CA01
ATC
furosemide; systemic
2.1
11.3
170
1027
Z51.5
ICD-10 Finland
Palliative care
3.8
11.3
48
137
M10.9
ICD-10 Finland
Gout, unspecified
3.5
11.0
52
163
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
16.6
10.4
16
10
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
5.6
9.9
28
53
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
26.8
9.9
13
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
9.5
124
694
H02AB06
ATC
prednisolone; systemic
1.9
9.4
205
1407
A05AA02
ATC
ursodeoxycholic acid; oral
9.0
9.4
19
22
I81
ICD-10 Finland
Portal vein thrombosis
37.6
9.1
11
*
D73.5
ICD-10 Finland
Infarction of spleen
37.6
9.1
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
9.0
203
1401
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
11.9
8.6
15
13
D73.1
ICD-10 Finland
Hypersplenism
+∞
8.4
8
*
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
8.4
8
*
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
+∞
8.4
8
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
8.4
8
*
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
8.4
8
*
L04AD01
ATC
ciclosporin; systemic
6.7
8.3
20
31
C90.0
ICD-10 Finland
Multiple myeloma
7.8
8.2
18
24
J05AB11
ATC
valaciclovir; oral
2.5
8.2
66
290
B01AB05
ATC
enoxaparin; parenteral
1.9
7.9
148
942
B04
ICPC
Blood symptom/complaint
45.9
7.7
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
7.7
54
219
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
7.6
112
651
D75.1
ICD-10 Finland
Secondary polycythaemia
25.6
7.6
10
*
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
81.5
7.4
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.0
7.3
22
46
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
7.2
78
396
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.8
7.2
19
34
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
7.0
33
104
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
7.0
40
144
B82
ICPC
Anaemia other/unspecified
4.5
7.0
23
53
J01MA12
ATC
levofloxacin; systemic
2.0
6.9
95
534
N02AA05
ATC
oxycodone; systemic
2.2
6.9
76
391
B74
ICPC
Malignant neoplasm blood other
22.9
6.7
9
*
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
12.5
6.6
11
9
TGC00
NOMESCO Finland
Bronchial lavation
4.7
6.6
21
47
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.8
6.5
20
43
D75.0
ICD-10 Finland
Familial erythrocytosis
70.9
6.4
7
*
A02BC02
ATC
pantoprazole; systemic
1.7
6.3
260
2076
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
6.3
38
143
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
6.3
6
*
V03AC03
ATC
deferasirox; oral
+∞
6.3
6
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
6.3
6
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.3
6.2
18
486
R18
ICD-10 Finland
Ascites
6.4
6.2
15
24
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
310
450
20.41
238.16
18.5
3.9
u/l
459.8
247.4
28.45
303
422
(3045142) Bone marrow Pathology biopsy report
144
45
46.83
232.35
1.8
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
142
59
34.88
208.59
1.5
1.1
u/l
76.7
27.3
1.86
127
51
(3042111) Morphology [Interpretation] in Bone marrow Narrative
130
68
26.59
173.48
1.9
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
102
38
34.53
153.78
1.3
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
202
300
11.50
143.19
18.7
4.4
%
2.6
0.8
9.66
135
102
(3027945) Reticulocytes/100 erythrocytes in Blood
257
520
10.33
140.36
7.3
2.5
%
2.4
1.8
9.02
237
474
(3023520) Reticulocytes [#/volume] in Blood
223
387
10.55
138.80
8.0
2.6
e9/l
85.9
70.2
5.29
187
314
(3004809) Band form neutrophils/100 leukocytes in Blood
102
59
22.13
128.81
15.6
3.9
%
2.6
0.8
5.30
88
49
(3002179) Metamyelocytes/100 leukocytes in Blood
175
265
10.24
120.16
19.3
4.4
%
2.0
0.4
12.35
106
74
(3021440) Promyelocytes/100 leukocytes in Blood
178
284
9.78
116.76
18.2
4.5
%
0.4
0.2
2.17
131
95
(3025159) Blasts/100 leukocytes in Blood
162
265
9.04
102.90
19.1
4.5
%
1.3
1.2
0.02
108
79
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
134
207
8.83
88.42
2.4
1.9
g/l
0.8
1.5
12.77
118
186
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
216
555
6.62
86.92
3.2
2.4
%
25.4
22.4
1.72
182
474
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
102
114
11.31
86.68
2.3
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
63
30
24.30
85.51
1.3
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
218
585
6.34
83.12
3.1
2.3
g/l
2.2
2.3
1.51
206
535
(3022948) Iron [Moles/volume] in Serum or Plasma
224
631
6.13
80.50
3.2
2.4
umol/l
13.6
12.7
0.91
212
576
(40765096) Chromosome analysis panel by Banding
48
15
35.75
75.09
1.2
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
76
72
12.52
71.83
8.7
6.8
iu/ml
1302.2
225.2
—
9
12
(3026493) Urate [Moles/volume] in Serum or Plasma
270
1006
5.28
66.96
7.2
2.8
umol/l
2277.3
10493.3
3.06
249
844
(42870588) Differential panel, method unspecified - Blood
300
1243
5.34
64.38
25.5
5.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
56
41
15.48
61.54
17.8
3.3
%
63.9
55.4
0.92
37
29
(3008757) Leukocyte morphology finding [Identifier] in Blood
54
50
12.15
51.36
22.7
4.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
334
1694
4.90
50.48
24.0
5.4
%
2.2
2.9
7.46
322
1577
(3002030) Lymphocytes/100 leukocytes in Blood
336
1725
4.87
49.59
24.2
5.6
%
20.0
26.4
20.87
323
1600
(3022096) Basophils/100 leukocytes in Blood
328
1655
4.73
49.55
22.9
5.4
%
1.3
0.6
11.00
315
1543
(3019069) Monocytes/100 leukocytes in Blood
333
1700
4.81
49.48
25.6
5.7
%
7.7
8.9
5.16
321
1590
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
55
59
10.50
47.23
9.8
2.9
%
66.5
59.1
2.20
55
59
(3000093) Morphology [Interpretation] in Blood Narrative
45
37
13.42
45.98
1.2
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
52
55
10.57
45.06
4.8
1.9
pg
31.0
32.8
1.61
52
55
(40760892) CBC W Ordered Manual Differential panel - Blood
193
742
3.83
41.38
19.5
4.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
316
1699
3.97
40.03
18.8
5.4
%
64.0
58.1
11.48
301
1585
(3001122) Ferritin [Mass/volume] in Serum or Plasma
286
1482
3.60
37.43
5.5
2.6
ug/l
381.9
151.1
3.02
274
1337
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
225
1018
3.45
36.43
2.8
2.1
mg/l
5.4
3.2
6.01
203
858
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
31
24
13.81
32.60
11.1
4.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
318
1871
3.45
31.66
20.8
5.3
e9/l
0.2
0.2
0.69
286
1655
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
331
1997
3.57
31.58
18.6
6.4
umol/l
14.2
12.0
1.16
323
1899
(3005719) IgG [Mass/volume] in Serum or Plasma
96
276
4.16
30.25
3.0
2.5
g/l
9.9
10.5
0.41
87
248
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
29
23
13.42
30.03
1.7
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
29
23
13.42
30.03
1.7
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
306
1816
3.19
28.86
16.3
5.2
e9/l
0.1
0.0
7.09
272
1582
(3001604) Monocytes [#/volume] in Blood
305
1807
3.19
28.85
16.3
5.2
e9/l
0.7
0.6
0.49
272
1565
(3019198) Lymphocytes [#/volume] in Blood
309
1846
3.21
28.77
17.2
5.3
e9/l
1.6
1.9
2.03
293
1638
(3003458) Phosphate [Moles/volume] in Serum or Plasma
137
521
3.35
28.28
5.5
5.4
mmol/l
1.1
1.0
2.90
126
473
(3013650) Neutrophils [#/volume] in Blood by Automated count
333
2110
3.30
27.32
30.0
8.6
e9/l
7.3
4.2
7.65
318
1862
(3012095) Magnesium [Moles/volume] in Serum or Plasma
155
647
3.14
27.22
5.3
3.3
mmol/l
0.8
0.8
0.44
147
594
(3011412) CD3 cells [#/volume] in Blood
30
30
10.65
26.77
5.2
1.5
e9/l
0.5
1.1
2.09
12
14
(4035726)
103
343
3.61
26.01
1.5
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
103
347
3.56
25.52
2.8
3.1
g/l
66.2
66.1
0.00
94
316
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
70
6.52
24.67
3.7
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
94
5.60
23.91
3.6
1.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
21
14
15.69
23.79
4.6
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
92
5.59
23.42
4.1
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
57
6.99
23.38
1.5
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
148
657
2.88
22.68
3.1
1.9
s
32.4
29.5
5.67
141
632
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
35
56
6.70
21.32
1.4
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
84
285
3.40
20.29
2.8
2.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
29
9.07
19.96
5.7
2.1
e6/l
3753.4
653.1
0.42
14
12
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
19
11.55
19.91
2.5
1.6
%
15.4
13.3
—
7
9
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
299
1967
2.59
19.54
11.5
7.1
mmol/l
1.2
1.2
3.35
237
1666
(3013727) Leukocytes other/100 leukocytes in Blood
18
13
14.39
19.45
12.4
5.0
%
60.7
47.9
0.72
18
13
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
20
10.97
19.25
5.9
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
20
10.97
19.25
5.9
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
26
34
8.06
18.87
2.9
2.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
21
10.45
18.62
5.9
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
16
10
16.56
18.59
1.6
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
24
8
31.60
18.52
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
25
32
8.22
18.46
1.5
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
85
307
3.19
18.45
3.7
3.8
mmol/l
1.2
1.2
3.12
73
262
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
22
24
9.59
18.35
5.7
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
22
24
9.59
18.35
5.7
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
22
24
9.59
18.35
5.7
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
22
24
9.59
18.35
5.7
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
206
1169
2.42
18.27
6.9
4.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
69
221
3.51
18.15
1.8
1.7
g/l
1.6
1.4
0.29
62
195
(3021589) Normoblasts [#/volume] in Blood
252
1573
2.39
17.86
30.2
9.6
e9/l
0.3
0.0
3.49
227
1297
(3019309) Folate [Moles/volume] in Red Blood Cells
161
827
2.48
17.69
2.0
1.8
nmol/l
1272.8
1173.7
0.58
117
618
(3048929) Epstein Barr virus Ab [Presence] in Serum
38
79
5.17
17.65
1.4
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
205
1175
2.38
17.61
7.4
3.9
ph
7.4
7.4
0.35
61
197
(3024932) HLA-DR beta [Type]
23
8
30.21
17.58
1.7
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
29
47
6.53
17.41
4.8
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
48
6.39
17.06
4.8
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
15
10
15.49
16.83
2.1
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
88
341
2.97
16.83
1.5
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
53
6.00
16.55
1.5
1.2
u/ml
287.3
288.1
0.00
15
27
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
29
50
6.13
16.39
1.3
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
80
301
3.02
16.08
2.7
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
262
1713
2.29
16.00
9.2
4.9
g/l
35.5
35.0
0.82
249
1591
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
26
41
6.67
16.00
5.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
26
41
6.67
16.00
5.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
26
41
6.67
16.00
5.0
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
102
445
2.68
15.51
8.8
2.8
umol/l
6.9
9.2
1.18
95
399
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
33
7.30
15.40
1.2
1.2
u/l
49.8
42.4
0.38
17
23
(3021960) Folate [Moles/volume] in Serum or Plasma
181
1028
2.28
15.40
2.1
1.6
nmol/l
17.9
20.8
1.85
169
856
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
137
698
2.39
14.94
3.1
1.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
13
11.91
14.49
8.7
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
60
204
3.24
14.26
1.5
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
20
27
7.71
14.08
3.5
2.0
—
—
—
0
0
(3036489) Thrombin time
45
128
3.80
14.03
2.4
2.0
s
24.0
21.4
0.57
40
117
(3033658) Prothrombin time (PT) actual/Normal
165
937
2.21
13.72
6.9
4.1
%
73.7
87.0
8.12
155
918
(40760888) Immunoglobulin light chains.free panel - Serum
37
94
4.20
13.45
5.0
3.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
251
1687
2.12
13.38
2.7
2.1
pmol/l
85.9
94.9
2.33
171
862
(3044640) Blood type and Crossmatch panel - Blood
196
1202
2.13
13.29
11.7
2.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
264
1816
2.12
13.14
9.7
6.1
mmol/l
1.2
1.2
1.10
245
1606
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
18
9.18
12.96
1.6
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
27
7.31
12.79
1.3
3.6
%
30.0
47.1
—
5
8
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
24
7.77
12.79
1.2
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
31
73
4.49
12.40
2.4
2.6
%
12.9
15.6
1.73
15
35
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
43
130
3.55
12.25
5.1
3.6
ratio
1.2
2.6
—
6
12
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
15
17
9.10
12.06
1.3
1.7
u/ml
2244.4
971.8
0.51
15
17
(40761536) Microorganisms panel - Urine sediment
70
286
2.72
11.94
4.9
3.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
75
318
2.63
11.89
1.5
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
133
3.47
11.83
5.2
3.7
mg/l
118.2
107.6
0.04
34
108
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
43
133
3.47
11.83
5.2
3.7
mg/l
45.8
30.1
0.65
35
109
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
25
51
5.13
11.82
1.2
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
55
4.96
11.80
1.2
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
371
2.52
11.80
2.0
2.3
g/l
0.2
0.2
0.25
71
348
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
248
1709
2.02
11.79
18.4
4.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
361
2879
2.35
11.38
25.4
7.7
u/l
97.6
80.0
6.34
351
2675
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
165
3.14
11.15
3.3
2.7
g/l
3.2
3.7
1.91
28
125
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
166
3.12
11.04
3.3
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
166
3.12
11.04
3.3
2.7
g/l
6.7
7.5
2.09
30
128
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
14
9.54
10.81
1.5
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
77
4.11
10.75
2.5
3.2
mmol/l
2.6
2.1
0.36
19
53
(4212803)
10
0
+∞
10.45
1.0
0.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
155
3.12
10.41
3.5
2.7
g/l
11.5
9.9
0.60
36
138
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
41
5.33
10.41
3.3
2.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
21
7.36
10.19
1.6
1.9
u/l
18.1
3.7
—
10
12
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
84
405
2.32
10.02
4.2
3.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
38
124
3.26
9.61
1.8
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
9
0
+∞
9.40
1.1
0.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
71
3.98
9.37
2.6
3.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
10
10.21
8.67
2.3
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
134
815
1.92
8.54
2.0
1.7
mg/l
1.5
1.3
0.25
103
640
(3032080) INR in Blood by Coagulation assay
234
1699
1.80
8.38
16.5
10.2
inr
1.5
1.3
1.84
95
443
(21494814) CD8 cells/100 lymphocytes in Specimen
13
9
14.83
8.25
3.1
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
11
9.28
8.11
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
11
9.28
8.11
1.0
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
145
922
1.85
7.97
21.1
6.5
—
—
—
0
0
(3010421) pH of Blood
30
95
3.31
7.96
2.5
3.2
ph
7.4
7.4
0.15
30
76
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
40
4.65
7.71
1.6
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
153
2.77
7.69
3.7
2.8
g/l
3.3
3.2
0.38
28
127
(3026782) Osmolality of Urine
128
800
1.84
7.35
2.9
3.1
mosm/kgh2o
511.1
565.1
2.47
115
677
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
88
486
2.01
7.32
2.0
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
42
4.42
7.28
1.5
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
60
3.81
7.28
1.5
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
76
400
2.09
7.20
1.4
1.7
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
10
5
20.41
7.16
1.1
1.0
%
85.5
113.0
—
10
5
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
13
7.85
7.14
1.0
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
192
1363
1.72
7.07
3.3
3.1
ng/l
3097.0
1535.9
2.55
172
1184
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
87
485
1.99
7.03
2.1
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
68
3.51
6.79
1.8
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
28
5.13
6.75
4.9
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
28
5.13
6.75
2.6
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
9
12.49
6.61
1.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
11
9
12.49
6.61
2.0
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
140
926
1.75
6.54
11.3
2.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
18
6.24
6.46
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
81
454
1.96
6.42
1.9
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
28
98
2.98
6.33
2.3
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
22
5.58
6.32
2.9
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
22
5.58
6.32
2.9
1.2
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
0
+∞
6.26
6.8
0.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
160
1111
1.69
6.21
5.6
3.2
u/l
34.0
31.9
0.59
154
1058
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
19
5.91
6.13
12.2
3.5
u/l
422.7
207.4
2.75
11
19
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
141
2.61
6.11
3.5
2.4
u/ml
0.4
0.3
0.11
23
72
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
53
3.70
6.10
4.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
53
3.70
6.10
4.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
53
3.70
6.10
4.8
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
53
3.70
6.10
1.6
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
37
154
2.53
6.05
3.3
3.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
6
15.27
5.92
1.1
3.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
282
2281
1.65
5.86
7.6
5.0
mmol/l
6.7
6.8
0.59
274
2143
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
104
2.81
5.71
1.5
1.5
iu/ml
2.2
0.1
—
5
28
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
51
3.64
5.66
5.0
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
17
5.99
5.65
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
49
240
2.17
5.56
3.5
2.9
e9/l
5.9
4.0
1.58
35
176
(44790048)
16
43
3.82
5.41
1.9
1.6
—
—
—
0
0
(44790047)
16
43
3.82
5.41
1.9
1.6
—
—
—
0
0
(44806118)
16
43
3.82
5.41
1.9
1.6
—
—
—
0
0
(44790049)
16
43
3.82
5.41
1.9
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
79
3.02
5.38
2.9
2.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
53
3.50
5.36
5.0
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
62
338
1.97
5.30
2.1
1.9
nmol/l
400.0
383.7
0.19
56
305
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
54
3.43
5.22
5.0
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
24
87
2.86
5.12
2.2
3.4
umol/l
44.4
35.6
0.49
18
75
(3007164) IgA [Mass/volume] in Serum or Plasma
98
624
1.73
5.10
1.6
1.5
g/l
2.3
2.7
0.76
72
355
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
19
5.36
5.06
1.3
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
51
265
2.04
4.98
5.4
3.8
mmol/l
1.0
2.0
1.10
34
204
(3003694) ABO and Rh group [Type] in Blood
127
876
1.63
4.87
1.9
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
28
4.38
4.85
2.9
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
63
3.11
4.73
1.9
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
35
160
2.29
4.70
2.6
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
134
954
1.58
4.45
4.3
3.7
—
—
—
0
0
(3009343) pH of Capillary blood
52
284
1.94
4.42
5.4
3.7
ph
7.4
7.4
—
8
25
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
12
7.63
4.37
1.2
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
91
592
1.68
4.34
2.1
2.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
56
3.12
4.28
1.7
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
52
288
1.91
4.25
5.4
3.7
kpa
4.9
5.1
0.72
46
265
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
175
2.15
4.19
6.0
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
204
1613
1.49
4.09
4.7
4.1
ng/l
35.4
59.2
0.61
168
1236
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
37
3.59
4.08
1.2
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
10
8.12
4.07
1.4
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
70
432
1.74
4.04
1.3
1.3
titre
275.0
455.9
1.32
16
98
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
24
4.24
3.90
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
85
1228
0.62
3.84
2.8
3.1
mmol/l
6.1
7.3
2.75
70
1004
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
15
6.10
3.83
1.3
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
158
1199
1.49
3.82
3.0
2.5
u/l
48.7
56.8
3.24
145
1107
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
29
3.86
3.82
1.5
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
8
8.87
3.78
1.1
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
8
8.87
3.78
1.7
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
86
2.51
3.60
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
41
3.24
3.52
4.3
2.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
64
2.72
3.43
2.8
2.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
10
7.09
3.37
1.1
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
140
1060
1.47
3.36
3.8
3.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
117
855
1.50
3.34
3.0
2.6
e6/l
3.9
4.5
0.53
111
755
(3025941) Bacteria identified in Stool by Culture
36
192
1.95
3.31
1.5
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
28
3.63
3.21
1.7
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
15
5.41
3.20
1.1
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
111
2.23
3.19
2.1
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
311
2740
1.45
3.17
6.1
4.1
mm/h
17.2
13.7
2.17
285
2478
(3002582) Erythrocytes [#/volume] in Urine
157
1228
1.43
3.13
3.8
3.4
e6/l
30.7
112.2
0.89
131
956
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
20
86
2.39
3.12
4.6
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
95
1284
0.67
3.02
3.9
4.0
mg/mmol
17.7
8.6
0.78
63
800
(3042631) Mycobacterium sp identified in Specimen
16
63
2.60
2.99
2.6
3.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
5
10.09
2.98
1.2
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
5
10.09
2.98
1.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
5
10.09
2.98
2.8
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
46
278
1.73
2.88
1.8
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
9
6.74
2.87
2.3
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
89
1205
0.67
2.82
3.2
3.2
mg/l
4208.5
157.7
1.81
61
771
(4281824)
10
31
3.28
2.79
1.4
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
114
858
1.44
2.76
1.6
1.8
pmol/l
568.4
8190091.3
0.50
86
696
(3030467) Casts [#/volume] in Urine by Automated count
142
1113
1.41
2.74
3.8
3.3
e6/l
0.5
0.5
0.07
119
841
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
199
0.34
2.74
1.4
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
47
291
1.69
2.70
3.7
2.6
ml/min/173m2
40.2
59.9
5.05
25
119
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
24
3.80
2.68
1.7
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
49
2.70
2.64
1.1
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
55
2.60
2.64
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
153
1224
1.38
2.60
3.9
3.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
20
4.05
2.58
1.8
2.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
7
7.21
2.55
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
7
7.21
2.55
1.2
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
11
5.51
2.55
1.7
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
33
3.08
2.54
1.7
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
165
1343
1.36
2.50
4.1
3.5
mmol/l
2.3
2.4
2.63
143
1146
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
26
3.51
2.49
1.8
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
26
3.51
2.49
1.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
21
3.86
2.47
1.8
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
214
1817
1.34
2.45
2.6
2.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
124
978
1.37
2.26
4.4
4.3
estimate
0.0
0.0
0.00
69
304
(3047189) Immunofixation for 24 hour Urine
7
18
3.93
2.26
4.1
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
150
1.85
2.25
1.4
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
29
3.15
2.23
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
9
5.60
2.22
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
80
2.17
2.21
2.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
80
2.17
2.21
2.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
58
401
1.51
2.15
10.1
4.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
116
1.94
2.15
3.5
3.6
—
—
—
0
0
(3013512) EKG study
148
1214
1.33
2.07
5.2
4.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
15
4.04
2.04
2.5
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
44
2.54
2.02
1.1
1.5
%
92.9
64.1
—
5
34
(40768806) Pleura Pathology biopsy report
13
57
2.32
1.99
1.2
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
98
1.98
1.98
1.5
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
63
451
1.46
1.98
6.1
8.4
%
95.5
95.3
0.08
63
434
(3016018) Differential panel - Cerebral spinal fluid
8
27
3.00
1.94
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
39
2.60
1.93
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
64
462
1.45
1.93
1.5
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
65
2.19
1.90
1.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
52
0.00
1.89
0.0
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
337
3594
0.74
1.89
5.0
5.4
mmol/l
2.2
2.6
16.65
307
3257
(4010399)
15
287
0.51
1.87
1.2
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
8
28
2.89
1.87
4.2
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
12
4.20
1.83
1.6
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.20
1.83
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
35
2.60
1.81
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
29
2.79
1.80
1.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
117
1.83
1.77
1.1
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
101
801
1.34
1.75
4.4
3.2
mmol/l
2.4
2.5
3.54
88
696
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
36
2.53
1.75
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
24
2.95
1.73
1.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
13
3.88
1.72
4.8
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
100
1236
0.75
1.71
3.3
4.8
%
23.3
21.1
0.83
48
640
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
163
1385
1.28
1.70
4.5
4.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
170
1455
1.27
1.67
4.2
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
504
0.65
1.66
10.4
7.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
66
494
1.39
1.64
6.3
8.0
kpa
4.8
5.1
1.82
66
471
(3021601) Nitrite [Presence] in Urine by Test strip
204
1789
1.26
1.62
5.6
5.6
estimate
0.0
0.0
0.00
75
316
(3018095) Leukocytes [#/volume] in Urine
164
1402
1.27
1.62
4.2
4.0
e6/l
114.1
90.7
0.15
134
1027
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
63
2.10
1.61
1.2
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
62
462
1.40
1.59
3.3
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
203
1789
1.25
1.52
4.2
4.0
estimate
0.0
0.0
0.00
78
318
(3019150) Specific gravity of Urine by Refractometry
63
817
0.73
1.49
3.9
4.4
kg/l
1.0
1.0
1.36
12
119
(3002032) Base excess in Venous blood by calculation
54
398
1.41
1.48
3.5
3.6
mmol/l
1.9
2.1
0.10
40
318
(3037467) Urinalysis macro (dipstick) panel - Urine
279
2554
1.25
1.46
5.5
4.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
33
221
1.53
1.46
6.8
3.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
28
2.52
1.45
2.7
3.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
28
2.52
1.45
1.3
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
33
222
1.53
1.43
2.5
2.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
16
88
1.85
1.43
1.2
1.2
mg/l
618.3
544.3
0.14
16
82
(3021447) Carbon dioxide [Partial pressure] in Venous blood
54
401
1.39
1.42
3.5
3.6
kpa
5.6
5.8
0.72
54
390
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
317
3372
0.79
1.41
5.8
6.6
mmol/mol
37.3
40.8
10.10
292
3100
(21494755) Public health laboratory ask at order entry panel
8
165
0.48
1.38
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
6
23
2.63
1.37
1.0
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
204
1814
1.23
1.37
4.2
4.1
estimate
0.0
0.0
0.50
77
306
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
17
2.96
1.36
2.6
5.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
333
3517
0.79
1.34
5.3
5.0
mmol/l
6.0
6.1
0.61
290
3166
(3000991) Gas panel - Venous blood
47
345
1.41
1.33
7.6
8.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
24
2.52
1.31
1.0
1.2
—
65.0
—
0
6
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
332
3504
0.79
1.30
4.7
4.8
mmol/l
3.9
4.5
20.79
301
3200
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
18
2.80
1.29
1.6
1.4
%
6.7
1.2
—
5
13
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
18
2.80
1.29
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
18
2.80
1.29
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
55
2.03
1.28
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
27
179
1.54
1.27
3.7
7.2
%
2.1
1.5
1.50
27
167
(3022217) INR in Platelet poor plasma by Coagulation assay
73
584
1.30
1.20
33.6
25.5
inr
1.7
1.3
1.48
11
77
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
64
1.90
1.19
1.6
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
330
3475
0.81
1.18
4.7
4.7
mmol/l
1.2
1.5
24.77
299
3145
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
170
1502
1.21
1.18
2.4
2.2
nmol/l
78.4
78.1
0.05
151
1289
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.2
—
2.0
—
0
13
(3051611) Lipemic interference index of Serum or Plasma
8
40
2.02
1.12
3.1
3.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
164
1459
1.20
1.04
2.5
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
34
2.08
1.03
1.3
3.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
34
2.08
1.03
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
73
882
0.79
1.02
2.5
3.2
ug/l
0.9
0.8
0.34
49
623
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
53
1.91
1.02
1.1
1.3
nmol/l
0.6
0.5
—
10
47
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
48
1.89
1.01
1.1
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
48
1.89
1.01
1.1
1.3
nmol/l
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
370
3549
1.25
1.00
41.7
16.6
mg/l
18.8
25.2
5.24
345
2849
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
259
1.38
0.98
1.8
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
23
157
1.49
0.98
1.1
2.0
u/l
32.3
39.4
0.64
18
138
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.1
—
4.6
—
0
13
(3019060) Gas panel - Arterial blood
38
286
1.36
0.97
3.3
5.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
84
992
0.81
0.96
1.8
1.6
mmol/l
1.7
1.3
2.99
72
813
(3002523) Influenza virus A Ag [Presence] in Specimen
6
27
2.24
0.94
2.5
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
27
2.24
0.94
2.2
2.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
27
2.24
0.94
2.5
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
71
1.71
0.89
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
330
0.71
0.85
4.2
3.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
15
96
1.58
0.85
1.5
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
213
0.65
0.83
1.4
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
138
1537
0.85
0.83
4.3
5.4
ug/l
3.4
2.7
0.29
129
1367
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
89
1.59
0.82
1.1
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
150
0.59
0.80
1.4
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
217
1.36
0.79
4.3
4.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.0
—
3.2
—
0
5
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.2
—
1.4
—
0
16
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
40
317
1.29
0.75
2.1
3.8
ng/l
80.6
82.1
0.04
33
278
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
44
354
1.27
0.74
3.0
2.4
u/l
35.6
33.2
0.19
37
293
(3022145) Colonoscopy Study observation
52
427
1.25
0.74
1.2
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
5
25
2.01
0.73
1.8
2.3
mmol/l
6.1
7.2
—
5
20
(3045788) Cell count panel - Pleural fluid
7
39
1.81
0.72
1.1
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
39
1.81
0.72
1.3
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
84
1.56
0.72
1.8
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
571
0.80
0.71
1.3
1.3
iu/ml
25.9
38.1
0.61
20
189
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
234
2191
1.14
0.71
4.6
3.3
u/l
92.2
54.9
3.29
222
2011
(1761868) Lipid panel - Serum or Plasma
121
1081
1.16
0.71
3.7
3.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
42
1.68
0.68
1.1
1.2
mu/l
57.7
55.2
—
7
37
(3035880) pH of Pleural fluid
5
27
1.86
0.68
1.4
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
179
0.66
0.67
1.3
1.2
iu/ml
66.0
161.8
—
5
69
(3027456) Digoxin [Moles/volume] in Serum or Plasma
14
94
1.51
0.67
3.1
3.3
nmol/l
0.8
0.8
—
7
73
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
166
0.65
0.65
1.4
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
59
500
1.21
0.64
6.9
7.9
mmol/l
0.3
1.3
0.72
43
390
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
29
1.73
0.64
2.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
49
409
1.22
0.62
7.5
8.9
g/l
104.6
120.5
5.65
49
398
(3020961) Endomysium IgA Ab [Titer] in Serum
19
139
1.38
0.61
1.1
1.1
—
32.2
—
0
5
(3044927) Protein electrophoresis panel - Urine
8
51
1.58
0.60
2.4
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
21
0.00
0.60
0.0
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
21
0.00
0.60
0.0
2.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
21
0.00
0.60
0.0
1.1
—
297.6
—
0
13
(3000963) Hemoglobin [Mass/volume] in Blood
378
3871
0.84
0.60
65.4
24.2
g/l
114.5
134.1
56.81
371
3803
(3010813) Leukocytes [#/volume] in Blood
378
3871
0.84
0.60
65.1
24.1
e9/l
12.8
6.8
9.43
368
3756
(3018405) Lactate [Moles/volume] in Arterial blood
22
166
1.34
0.60
2.5
3.2
mmol/l
1.4
1.4
0.11
22
161
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
72
1.54
0.59
4.2
2.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
378
3870
0.85
0.59
64.9
24.0
e12/l
3.9
4.4
24.86
369
3753
(3007461) Platelets [#/volume] in Blood
378
3869
0.85
0.58
65.1
24.0
e9/l
308.9
239.4
10.31
371
3767
(3035941) MCH [Entitic mass]
378
3869
0.85
0.58
64.6
23.9
pg
29.8
30.4
2.93
371
3803
(3024731) MCV [Entitic volume]
378
3869
0.85
0.58
64.7
24.0
fl
93.1
91.6
2.44
371
3804
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
54
1.49
0.57
2.1
4.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
88
0.56
0.56
1.2
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
169
1.32
0.54
1.1
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
135
1239
1.13
0.54
2.2
2.1
u/l
77.3
203.3
9.30
124
1161
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
223
1.27
0.54
10.3
11.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
77
863
0.87
0.50
3.4
4.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
546
0.84
0.48
1.3
1.3
u/ml
14.6
15.6
0.03
18
197
(1002224) Polysomnography panel
8
120
0.66
0.46
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
275
2643
1.11
0.46
4.3
3.8
pmol/l
15.2
15.0
0.96
253
2327
(3049717) Cytology report of Urine Cyto stain
23
184
1.26
0.44
2.8
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
317
3073
1.11
0.43
42.5
18.0
%
34.3
39.2
9.27
175
2018
(3023323) Follitropin [Units/volume] in Serum or Plasma
8
56
1.44
0.42
1.4
1.2
iu/l
19.0
21.9
—
8
47
(4268621)
5
33
1.52
0.41
1.6
2.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
60
1.34
0.40
1.8
1.8
pmol/l
213.6
234.6
—
8
53
(3050129) First trimester maternal screen panel - Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
18
0.00
0.40
0.0
1.4
—
112.4
—
0
13
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.6
—
0
5
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
2.6
—
0
5
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
1.3
—
0
6
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
1.0
—
0
11
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
48
421
1.16
0.39
1.3
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
40
458
0.86
0.36
3.7
4.2
ug/l
3.1
42.1
1.47
26
386
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
35
403
0.86
0.34
2.3
2.4
ug/l
4.6
6.9
0.84
27
354
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
44
1.37
0.34
1.3
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
6
44
1.37
0.34
1.2
1.3
—
78.7
—
0
5
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
109
1.29
0.34
1.3
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
39
341
1.16
0.33
3.5
2.8
kpa
4.1
4.4
0.60
39
329
(3020891) Body temperature
20
164
1.23
0.33
3.6
3.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
330
3370
0.92
0.30
4.7
4.3
mmol/l
1.5
1.3
3.84
298
3033
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
24
203
1.19
0.30
2.8
3.6
mmol/l
23.9
24.2
0.13
24
188
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
120
1.26
0.30
1.4
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
28
321
0.86
0.27
1.4
1.8
%
1.8
1.6
0.35
21
268
(40768797) Stomach Pathology biopsy report
57
521
1.11
0.27
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
86
1.29
0.26
2.3
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
85
794
1.09
0.26
4.0
3.9
ng/l
316.2
261.2
0.10
74
667
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
15
181
0.82
0.25
3.5
3.8
u/ml
14.8
1423.8
1.01
15
158
(3015171) Extractable nuclear Ab [Units/volume] in Serum
14
114
1.24
0.25
1.1
1.2
—
1.9
—
0
10
(3044889) 12 lead EKG panel
255
2613
0.94
0.22
5.1
4.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
95
0.73
0.22
1.6
2.7
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
6
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
11
89
1.24
0.21
5.5
11.1
mmol/l
12.5
11.2
0.37
11
80
(3018572) Chloride [Moles/volume] in Blood
11
89
1.24
0.21
5.5
11.1
mmol/l
104.5
105.0
0.12
11
80
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
89
1.24
0.21
1.4
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
63
1.11
0.17
1.4
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
69
0.72
0.17
2.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
1.3
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
130
1.16
0.16
4.7
6.1
—
—
—
0
0
(4094501)
7
90
0.77
0.14
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
100
0.80
0.13
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
344
0.92
0.12
1.3
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
181
1.11
0.12
1.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
114
1.14
0.12
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
114
1.14
0.12
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
363
3660
0.96
0.11
36.2
15.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
362
0.93
0.11
1.4
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
115
1.13
0.10
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
68
706
0.96
0.10
3.8
2.8
e6/l
0.9
1.1
0.33
38
414
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.0
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
55
1.09
0.09
1.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
75
0.80
0.07
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
22
235
0.93
0.07
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
153
0.91
0.07
1.3
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
82
0.85
0.07
1.1
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
84
0.83
0.07
1.0
1.1
—
11.0
—
0
8
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
86
1.05
0.07
1.7
1.7
nmol/l
43.4
46.4
—
9
79
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
90
0.89
0.07
1.1
1.3
—
2.4
—
0
16
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
326
3239
1.02
0.06
5.2
4.7
mu/l
2.3
2.0
2.64
303
2883
(4034850)
11
120
0.91
0.05
19.5
11.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
666
1.02
0.04
3.8
3.1
e6/l
1.1
2.1
0.81
35
378
(3023103) Potassium [Moles/volume] in Serum or Plasma
373
3743
0.98
0.03
43.6
19.9
mmol/l
4.1
4.0
7.27
363
3640
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
375
3761
0.98
0.02
32.3
11.1
u/l
25.1
25.1
0.01
364
3612
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
337
3358
1.01
0.02
36.3
15.5
ml/min/173m2
71.6
75.0
2.38
306
2770
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
14
148
0.94
0.02
2.2
3.0
u/ml
17.0
63.8
1.06
14
142
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
50
509
0.98
0.02
4.2
4.9
%
27.9
32.3
1.95
38
334
(3019550) Sodium [Moles/volume] in Serum or Plasma
373
3738
0.99
0.01
41.1
19.7
mmol/l
139.0
139.6
3.38
365
3635
(3045414) Leukocytes [Presence] in Urine
15
146
1.03
0.00
1.9
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
147
1.02
0.00
3.5
3.1
g/l
0.2
0.3
—
10
54
(3000492) Spirometry study
31
307
1.01
0.00
1.4
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
14
141
0.99
0.00
3.0
3.0
mmol/l
4.0
4.0
0.45
14
125
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
71
708
1.00
0.00
1.2
1.2
u/ml
7.2
1.6
0.40
12
179
(3022621) pH of Urine by Test strip
25
249
1.00
0.00
3.6
3.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
367
1.01
0.00
1.4
2.2
ug/g
298.8
143.8
0.36
24
290
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
10.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
16.6
—
0
8
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
9.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
18.2
—
1627.3
—
0
9
(3023419) Bacteria identified in Sputum by Culture
6
64
0.94
0.00
1.7
3.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
9.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
41.7
—
0
9
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.2
—
10948.8
—
0
5
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
70
1.00
0.00
1.1
1.2
—
49.0
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
70
1.00
0.00
1.1
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
88
0.91
0.00
1.1
1.3
—
3.1
—
0
15
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
10.7
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
96.5
—
0
6
(3025315) Body weight
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
77
0.91
0.00
1.6
1.8
%
46.0
59.4
—
7
77
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.5
—
5.8
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.9
—
0
6
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
76
0.92
0.00
1.1
1.2
—
1.1
—
0
6
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
14.9
—
940.9
—
0
9
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.0
1.9
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
12.3
—
6.7
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint CHRONMYELOPRO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CHRONMYELOPRO | 4.416 [3.64, 5.36] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.395 |
During the follow-up period (1.1.1998 — 31.12.2019), 638 out of 1093 females with CHRONMYELOPRO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CHRONMYELOPRO | 4.304 [3.38, 5.49] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 708 out of 1119 males with CHRONMYELOPRO died.
Mortality risk
Mortality risk for people of age
years, who have CHRONMYELOPRO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.402% | 0.735% |
| 5 | 2.414% | 4.819% |
| 10 | 6.333% | 12.442% |
| 15 | 12.699% | 21.902% |
| 20 | 20.929% | 35.833% |
Relationships between endpoints
↥Index endpoint: CHRONMYELOPRO – Chronic myeloproliferative disease
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data